ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学会発表・講演等
  2. 口頭発表

Carbon Ion Radiotherapy for Locally advanced Adenocarcinoma of the Uterine Cervix.

https://repo.qst.go.jp/records/61941
https://repo.qst.go.jp/records/61941
e689bb55-ce14-400f-9880-73b319eed210
Item type 会議発表用資料 / Presentation(1)
公開日 2006-12-05
タイトル
タイトル Carbon Ion Radiotherapy for Locally advanced Adenocarcinoma of the Uterine Cervix.
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_c94f
資源タイプ conference object
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Kato, Shingo

× Kato, Shingo

WEKO 612959

Kato, Shingo

Search repository
Ohno, Tatsuya

× Ohno, Tatsuya

WEKO 612960

Ohno, Tatsuya

Search repository
Tsujii, Hirohiko

× Tsujii, Hirohiko

WEKO 612961

Tsujii, Hirohiko

Search repository
Suzuki, Michiya

× Suzuki, Michiya

WEKO 612962

Suzuki, Michiya

Search repository
加藤 眞吾

× 加藤 眞吾

WEKO 612963

en 加藤 眞吾

Search repository
大野 達也

× 大野 達也

WEKO 612964

en 大野 達也

Search repository
辻井 博彦

× 辻井 博彦

WEKO 612965

en 辻井 博彦

Search repository
鈴木 通也

× 鈴木 通也

WEKO 612966

en 鈴木 通也

Search repository
抄録
内容記述タイプ Abstract
内容記述 Abstract
Purpose: To evaluate the toxicity and efficacy of carbon ion radiotherapy (CIRT) for locally advanced cervical adenocarcinoma by a phase I/II dose-escalation study.
Methods and Materials: Between April 1998 and March 2006, 32 patients with cervical adenocarcinoma were treated with CIRT. Histologically, 24 patients had adenocarcinomas and 8 had adenosquamous carcinomas. Seven patients had stage IIB, 23 had stage IIIB, and 2 had stage IVA disease. The median tumor size was 6.5 cm. The treatment consisted of whole pelvic irradiation and local boost. The clinical target volume (CTV) of whole pelvic irradiation included the cervical tumor, uterus, parametrium, at least the upper half of the vagina, and pelvic lymph nodes. The dose of the whole pelvic irradiation was fixed at 36.0 gray equivalent (GyE) in 12 fractions. In local boost irradiation, the CTV was shrunk to the cervical tumor and surrounding tissues, and an additional dose of 26.4-35.2 GyE/8 fractions was delivered (total dose: 62.4-71.2 GyE). The dose to the GI tracts was limited to less than 60 GyE. The median follow-up duration for all patients was 21.5 months (range, 6-81 months).
Results: No patient developed severe acute toxicity. No patient developed major late complications except for one patient with a rectovaginal fistula. Local control was obtained in 4 of the 7 patients receiving a total of 62.4-64.8 GyE, in 7 of the 9 patients receiving 68.0 GyE, and in 11 of the 13 patients receiving 71.2GyE. The 3-year overall survival rates for all patients and the 25 patients with stage IIIB or IVA disease were 66% and 60%, respectively.
Conclusions: Although the number of patients was small, the results have suggested that CIRT provided favorable local tumor control and overall survival with acceptable rates of late complications in the treatment of locally advanced cervical adenocarcinoma.
会議概要(会議名, 開催地, 会期, 主催者等)
内容記述タイプ Other
内容記述 NIRS-CNAO Joint Symposium on Carbon Ion Radiotherapy
発表年月日
日付 2006-11-28
日付タイプ Issued
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 21:36:31.496468
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3